The Centers for Medicaid & Medicare Services is continuing the drumbeat of modernizing the two gargantuan programs it runs to generate more accountability, greater transparency, and provide better value for both patients and taxpayers. Administrator Seema Verma announced on Thursday a new proposed rule that would bring more accountability into “Accountable” Care Organizations (ACOs),...
Congress ordered the Centers for Medicare and Medicaid Services (CMS) to come up with a new payment system for the more than 400 million clinical laboratory tests that Medicare pays for each year so that prices would be more closely aligned with those paid by private insurers. But the new system relies on data...
President Trump’s plan to lower prescription drug costs uses a surgeon’s scalpel to address a range of issues, offering nearly 30 policy recommendations to modernize payment policies, weed out counter-productive regulations, improve price transparency, and expand competitive price negotiations. The plan reflects the complexity of the industry and the regulatory system that governs government approval...
President Trump delivered a major speech to describe steps his administration is taking to address the high cost of prescription drugs. Congress should be called on to fix two problems with the federal government’s largest prescription drug program: Medicare Part D. That program has made prescription medicines more affordable for millions of seniors, offering...
Thirty-nine health policy experts and representatives of a broad cross-section of organizations joined in signing a comment letter to the Centers for Medicare and Medicaid Services regarding its proposed rule on Short-Term, Limited-Duration Insurance. They argue that the Obama administration exerted “regulatory overreach” in limiting the sale of short-term policies to 90 days and prohibiting...